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CHAPTER I
INTRODUCTION .

Weil and Stetten (194?) were the first to show that lipid
mobilizing activity might be demonstrated in the urine during
fasting.

They found that an alkaline extract of urine from

fasting rabbits when injected into mice caused an increase in
liver fata similarly prepared extracts of urine from fed rabbits
had no such effect.
Chalmers et al. (1958) extended these observations to
humans.

Subjects were fasted for thirty-six hours.

From the

urine collected during the last twenty-four hours of this period,
a fat-mobilizing material could be precipitated at pH 5·3 with
two volumes of ethanol.

Subs.equent separation, and extraction

of the material with dilute sodium carbonate solution resulted
in an alkaline extract which, upon injection into mice, produced
an increase in liver fat.

Animals receiving the urine extracts

from the same subjects on a normal diet, without fasting •. had
liver fat values very similar to those found in the salineinjected animals.
When the dose of fasting urine extract was varied, the
increase in liver fat was found to be linearly related to the
log dose.

For convenience, the active material has been referred

to as Fat Mobilizing Substance (FMS) (Chalmers, 1965).

-2-

In the intact mouse, subcutaneous injection of FMS caused
a prompt fall in blood sugar, a rise in blood ketones as well as
an increase in liver fat (Chalmers et al. 1960).
blood sugar preceded the rise in blood ketones.

The fall in
The effect on

liver fat and blood ketones were maximal at six hours and subsided within twelve hours (Chalmers et al. 1960a).

Blood lipids

including total lipids, phospnolipids, cholesterol and free
.
fatty acids also increased six hours after FMS injection
(Chalmers, 1965).

The effects on liver fat and on the circulati g

levels of lipids and ketone bodies can be considered as the
results on an increased rate of entry into the liver of free
fatty acids released from adipose tissue.

The following

evidence support this view: (1) both rats and mice injected
with

FN~

show a prompt rise in plasma free fatty acid concentrat

ion (Chalmers, 1965); (2) surviving epididymal adipose tissue
removed from rats previously injected with FMS releases free
fatty acids faster than tissue from saline-injected animals
(Chalmers, 1965); (J) addition of FMS to rat adipose tissue in
vitro causes a marked increase in the rate of release of free
fatty acids (Chalmers, 1965).

This last parameter has been

utilized as the basis for the measuring the in vitro lipolytic
activity of FMS.
Repeated administration of FMS into animals for a period
of up to three weeks causes weight lossa control animals

-

-3receiving- saline or non-fasting urine extract do not lose
weight (Chalmers et al. 1960a).
supression of appetites

Loss of weight is not due to

the treated animals remain in good

condition and their food intake does not differ significantly
from that of the controls (Chalmers et al. 1960).

Carcass

analysis showed that loss of fat accounts for more than half
the weight loss; the remainder, being water and body protein,
is unchanged (Chalmers et al. 1960).
Kekwick and Pawan (1963) studied the effects of administering FMS to mice kept in a metabolic chamber.

Respiratory gas

exchange was measured as well as carbon excretion in stools and
urine.

Daily injections of Ffl'lS caused only a small rise in

oxygen consumption, carbon dioxide optput did not increase and
sometimes actually diminished.

Carbon balance, however, became

markedly negative due to increased loss of carbon in the urine
and, to a lesser extent, in the stools.

Similar changes were

found after daily injections of FMS for three weeks.

The form

in which the additional carbon is excreted is not completely
clear but it is probably mainly in the form of ketone bodies
representing the disposal of free fatty acids mobilized in
excess of energy requirements.

These results appear to exclude

the possibility that FMS, besides releasing free fatty acids
into the circulation, may directly augment their oxidation in
peripheral tissues (Chalmers, 1965).

Moreover, FMS has been

-4demonstrated to have no effect on the utilization of short-chain
fatty acids by the isolated perfused rat heart (Chalmers, 1965).
Following the extraction of FMS from the urine of fasting
man, Stevenson et al. (1964) reported the extraction of a similar
material (FMS I) by essentially the same procedure from the
·urine of fasting rats that also showed -fat mobilizing and hypoglycemic properties in vitro

~nd

in vivo.

FMS I differed from

the material isolated by Chalmers et al. in that a single
subcutaneous injection in the rat caused a transient but
nounced decrease in food intake.

pro_~_

Beaton et al. (1964) fraction-

ated FMS I into FMS IA and FMS IB on the basis of solubility
in alkaline and water solutions.

These two fractions were

chemically distinct1 the anorexigenic property of FMS I
attributable to the IA component and. the fat mobilizing property
to the IB component.
More recently, FMS was extracted from the urine of fastin
chickens(Nir et al. 1969).

The method used to extract FMS was

essentially that of Chalmers et al. (1958) as modified by
Stevenson et al. (1964) and Beaton et al. (1964).

Injection of

chicken FMS into chicken caused transient decrease in food intake
and transient increase in plasma free fatty acids.

These effects

were accompanied by persisting decrease in plasma triglyceride,
cholesterol and lipid phosphorus •

Slight elevation of blood

glucose occurred but it was not statistically significant.

-5These results, so widely different from those obtained with
mammals, can only be possible if the process for the metabolism
of carbohydrate and fats differ widely in chickens and mammals.
Some data indicate such a possibility.

Protamine zinc insulin,

for example, causes hyperphagia in mammals but, conversely,
it causes anorexia in chickens (Lepkovsky et al. 1965).

More-

over, the FMS from the urine pf fasting chickens has both
anorexigenic and fat-mobilizing properties that cannot be
separated into two fractions by the procedure of Beaton et al.
( 1964)

~

FMS activity has also been detected in the urine of fasting mice, dogs, sheep, goats and horses (Kekwick et al. 1967)
but little information has been reported on the nature of these
fat-mobilizing materials.

Conditions in Which FMS Activity Is Found
FMS activity can be detected in human urine after about
twelve hours of fasting (Chalmers et al. 1958).

In health, no

activity is detectable with normal unrestricted diets or with
low-calorie diets provided the daily carbohydrate intake exceeds
about 80 gms. (Gordon, 1970).
Chalmers et al. (1960a) reported the effect of progressive
restriction of dietary carbohydrate in an obese

patient.

was collected on the last two days of each four-day dietary

Urine

"'"

-6-

Diets provided one thousand Calories of which one
perio d ·
hundred were in the form of protein and 900 as carbohydrate
plUS fat daily.

Urine extracts were assayed for FMS activity

by the ketogenic effect in mice.

At first, when carbohydrate

provided ninety percent of the remaining calories, no ketogenic
activity could be detected in the urine.

FMS activity began

to appear in the urine when tne proportion of calories provided
by carbohydrate was reduced to half and began to increase progressively with further carbohydrate restriction.

This relation-

ship holds true when the diets were given in the reverse order.
In very obese patients, fasting and low carbohydrate
diets appear to elicit a smaller output of FMS than in nonobese
subjects (Chalmers, 1965).

It is possible that a primary defect

of this mechanism plays a part in the development of obesity.
In contrast, hypothalamic-obese rats excrete a greater amount
of FMS than do the control animals regardless of whether laboratory chow or a high-fat diet is fed prior to fasting (Beaton
et al. 1966).

It would seem that the ability of these animals

to produce and excrete a substance for mobilizing fat is not
impaired.

Adipose tissue taken from these animals has been

reported to have a reduced lipolytic response to FMS (Beaton
et al. l966a).

Thus the gain of body fat in these animals may

be due to an increased food intake and lipogenesis and enhanced
by a reduced response of their adipose tissue to FMS.

-?Beaton et al. (1965) reported observations on the effects
of previous diet on excretion of FMS in the urine of fasting
rats.

Four diets (high carbohydrate, hieh protein, high fat

and high protein-high fat) were investigated and the greatest
. excretion of FMS was observed when the high protein-high fat
diet was fed ad libitum prior to fasting.

The greatest total

activity excreted per twenty-four hours was obtained with the
diet highest in noncarbohydrate calories.
Chalmers (1965) observed a progressive increase.

in.urinar~

FMS activity in two lean subjects given a low-calorie, low
carbohydrate diet for five days.

Karninen et al. (1962), howevei,

have reported results suggesting that less activity is excreted
on the second day of fasting than on the first day in humans.
Crisp et al. (1968) suggested that starvation, a powerful
stimulus for FMS production, if continued without nutrient
intake, might cause a

temporar~

exhaustion of the secretory

cell~.

Beaton et al. (1966) studied the effect of duration of fasting
peridd on excretion of lipid-mobilizing activity in the urine of
rats and observed that the greatest excretion of such activity
occurred in the first twenty-four hours and diminished thereafter up to seventy two hours.

These observations seem to

con~

firm the observations made by Karninen et al. and Crisp et al •

.

Braun and Mosinger (1961) reported the urinary excretion
of a fat-mobilizing substance by rabbits during exposure to
cold.

Beaton et al. (1964a) observed that FMS was excreted by

-8-

fed rats during acute exposure to cold but not by rats during
feeding at ambient temperature.

Stevenson et al. (1965)

studied the effect of environmental temperature on the excretion
of FMS in the urine of fasting rats and observed a progressively
increasing excretion with decreasing environmental temperature
from 30° to 5°C.
The effect of age and sex on the excretion of FMS was
reported by Beaton et al. (1966).

These investigators observed

that young rats excreted a greater

~ount

rats, the greatest excretion per
approximately 37 days of age.

~00

of FrvJ.S than did adult

grn body weight being at

The amount of FMS excreted did

not vary apppreciably between 37 and 62 days of age but was
decreased between 62 and 78 days.

It has been generally accept-

ed that puberty in the rat is reached between 50 and 70 days.
At the age of 27 days, i.e., prepuberty, male rats fed a highfat diet excreted more FMS with a higher activity than did
female rats.

However, at 90 days of age (post-puberty), there

was no apparent sex difference in the amount of total activity
of FMS excreted per rat but when expressed per 100 gm body
weight, female excreted more FIVIS than did male .•
Stevenson and Beaton (1965) observed that infant and
young children excreted more fat-mobilizing activity than did
young male adults during an 18 or 24-hour fast.
FMS has been detected in the urine in a number of clinica
situations where carbohydrate intake was not severely restricted

-9Activity was found in lipoatrophic diabetes (Chalmers et al.
19 6oa, Louis et al. 1960, 1962) and diabetic ketosis (Chalmers,
1965). Goth et al. (1965) confirmed the presence of FMS in the
urine of patients with diabetes.

In contrast, alloxan-diabetic

rats excrete less total activity of FMS than do control animals
(Beaton et al. 1966).

FMS and Pituitary Hormones
The ability to produce FMS

i~

response to fasting and

other conditions associated with increased catabolism of fat
depends on the integrity of the adenohypophysis (or adjacent
hypothalamus).

Chalmers et al. (1960a) reported seven studies

in six patients with anterior pituitary deficiency.

They

included a patient whose pituitary had been removed for breast
carcinoma three weeks before, three cases of chromophobe
adenoma, a patient with Sheehan's syndrome and a woman in whom
the cause of hypopituitarism was not known.

All patients were

receiving cortisone and thyroid in replacement dosage.

No fat-

mobilizing or ketogenic activity was detected in the urine by
Jn

vitr~

or

in

vivo techniques even though the_patients were

subjected to severe carbohydrate restriction or fasting for up
to thirty~six hours.

Pituitary-dependence was also demonstrated

in rats (Beaton et al. 1964a) and in goats (Kekwick et al. 1967).
Urine extracts from fasting hypophysectomized rats contained no
fat-mobilizing activity in vitro and in vivq (Beaton et al.

-1064a). While the urine of fasting, normal and sham-operated
19
control animals contained fat-mobilizing activity, no such
activity could be detected in the urine of hypophysectomized
goats fasting for up to five days (Kekwick et al. 1967).

An

intact pituitary gland, therefore, appears to be necessary for
the production of FMS in these mammals.

However, the relation-

ship of the pituitary gland and its hormones to the fat-mobilizing substance of urine is not clear.

Whether the pituitary is

the origin of FMS in mammals or whether, it simply controls the
formation and release of FMS elsewhere, is not known.
Comparisons of FMS with lipolytic substances of known
pituitary origin do reveal important differences1 however.
Preparations of FMS show weak melanophore-stimulating and in
vitro corticotrophic activity (Chalmers, 1965) but the evidence
against the fat-mobilizing property being due to corticotrophin
or MSH appears to be quite conclusive.

Thus comparison of a

preparation of FMS with corticotrophin A1 peptide gave widely
differing potency ratios in three assay systems(Chalmers et al.
1960a).

These were (FMS/corticotrophin)a (1) release of corti-

coids by rat adrenal in vitro - 5/1000; (2) release of free
fatty acids by rat epididymal adipose tissue in vitro - 25/1000;
(J) increase in blood ketones in intact, unanesthetized mice -

100/1.

FMS, unlike corticotrophin, cannot be reversibly

inactivated with hydrogen peroxide and cysteine (Chalmers et al.

-11-

19 6oa). Both calcium and magnesium ions are required for the
lipolytic effect of corticotrophin in vitroa FMS requires
calcium but not magnesium (Chalmers, 1964, Beaton et al. 1965,
1966).

Finally both corticotrophin and melanocyte-stimulating

hormone are lipolytic in the rabbit as well as in the rat
(Raben et al. 1961) but FMS js inactive in
tissue (Chalmers, 1965).

lepo~ine

adi.r>ose

Species differences in the responsive-

ness of adipose tissue also differentiate FMS from the lipolytic
peptides isolated from anterior pituitary glands by

Rudma~

et

al. (1961) and by Friesen et al. (1962), since these substances
are active in rabbits and ginea pigs but not in rats or mice.
Administration of commercial corticotrophin to normal subjects
does. not lead to the appearance of fat-mobilizing activity in
the urine and the urine of a totally adrenalectomized patient
with a corticotrophin-secreting pituitary tumor contained no FMS
while on an unrestricted diet but responded normally to carbohydrate deprivation with excretion of FMS (Chalmers, 1965).
This ·observation supports the view that FMS is not corticotrophin-dependent and shows that functioning adrenal glands are
not required for the production of activity in response to
restriction of carbohydrate intake.
A preparation of FMS tested for thyrotrophic activity
proved to be inactive (Chalmers, 1965).

In one of the two

thyrotoxic patients, FMS activity was present in non-fasting

-12ur1·ne and disappeared during treatment with carbimazole while
plasma TSH presumably increased. Therefore, FMS activity could
not be attributed to TSH (Chalmers, 1965).
The relationship between FMS and growth hormone remains
unsettled.

The rise in plasma free fatty acids produced by

~owth hormone is slower than that due to FMS and in vitro,

growth hormone shows little or no lipolytic activity (Vaughan
and Steinberg, 196J).

Preparations of FMS do not show growth-

promoting activity and do not cross-react with antisera to
human growth hormone (Chalmers et al. 1960).

Chalmers et al.

(1960a) could find no fat-mobilizing activity in the urine of
two hypophysectomized patients after injection of human growth
hormone (5 mg intramuscularly) although plasma free fatty acids
rose two- to three-fold in each case.
Interestingly, FMS has been detected in the urine of
hypophysectomized chickens (Nir et al. 1969).

The relationship

between FMS and hormones of pituitary origin requires elucidatio '•

Lipolytic Action of FMS
Factors influencing the in vitro lipolytic action of FMS
have been studied (Beaton et al. 1966a).

Adipose tissue removed

from rats previously exposed to cold exhibits increased response
to FMS while adipose tissue of rats rendered hyperphagic and
obese by bilateral electrolytic ablation of the ventromedial

-13region of the hypothalamus has decreased response.

Previous

feeding of a high-protein diet or a noncarbohydrate high fat
diet inhibited lipolytic response to FMS in vitro.

Of the

adipose tissues tested, lipolytic response to FMS was in the
order epididymal) perinephric) omentum.

There was no sex

difference in the response of adipose tissue in vitro.
Cahill et al. (1961) studied the in vitro effect of

fi~S

on glucose metabolism and observed that FMS increases the
incorporation of glucose carbon into glyceride-glycerol in the
same manner as does ACTH, epinephrine and growth hormone (Cahill
et al. 1960, Lynn et al. 1960 and Leboeuf et al. 1961).

These

workers suggested that FMS primarily accelerates lipolysis and
does not exert its action via inhibition of esterification.
The rise in intracellular fatty acids resulting from accelerated
lipolysis induces increased glucose uptake and glycerideglycerol synthesis and increased metabolism of glucose via the
Embden-Meyerhof pathwar and oxidation by the tricarboxylic
pathway.
It would appear that these in vitro observations support
the in vivo situation.

Louis et al. (1962, 1963) reported that

FMS has strong anti-insulin activity in the dog and suggested
that the anti-insulin effect may be due to the increased fatty
acid production since Randle et al. (1963) have shown that
glucose uptake by muscle is inhibited by increased availability

-14of free fatty acids for oxidation.
The in vitro relationship between FMS and glucose was
further studied by Beaton et al. (1966a) who observed that the

in

vitro lipolytic response of FMS can be abolished by addition

of glucose to the incubation medium. ·It is possible that glucose
aids triglyceride synthesis resulting in a .net decrease in
lipolysis.
In vivo, the hypoglycemic but not the ketonemic effect
of FMS can be abolished by intraperitoneal injection of glucose
at the time of FMS injection (Chalmers, 1965).

It has been

shown that the hypoglycemic and fat-mobilizing properties
of FMS are not mutually dependent and can be dissociated by
ultrafiltration (Beaton et al. 1966b).

Mechanism of Action
The mechanism by which FMS augments the lipolytic reaction
in rat adipose tissue has been examined in the light of claims
that all lipolytic agents act by releasing noradrenaline from
tissue stores (Paoletti et al. 1961).

Chalmers (1965) noted

that most adrenaline-blocking agents when addeq, in vitro,
depress the lipolytic response to FMS.

This is true of nethalide

as well as dibenzyline, tolazoline and dihydroergotamine.
Dichloroisoproterenol inhibits the lipolytic effect of FMS to a
certain degree but its inhibition is far from being complete
even at high concentration.

Adipose tissue removed from rats

-15previously treated with reserpine to deplete tissue stores of
catecholamines was found to be fully responsive to FMS (Chalmers
l965).

The view that noradrenaline is an essential mediator of

the lipolytic response to FMS is unsettled.
Since FMS appears to be a lipolytic agent, it would be
reasonable to expect its action to be mediated by cyclic AMP
which is a mediator for many lipolytic agents (Robison et al.
19?1a).

Nathan and LaRoche (1970) suggested that cyclic ~~P

might be the mediator of the lipolytic response of adipose
tissue to FMS.

At the time the

wqr~

described in this dissertat

ion was initiated (1969), no experimental data had yet been
presented to support this view.

Isolation and Purification of FMS
FMS has been isolated from the urine by a three-stage
procedure involving• benzoic acid precipitation, extraction
with water or sodium carbonate solution and alcoholic precipitation (Beaton et al. 1964, Kekwick et al. 1967).

Chalmers

et al. (1960a) reported that the use of oxycellulose increased
the potency of the isolated product twenty to thirty times
While Beaton et al. (1966b) reported that millipore filtration
and carboxymethylcellulose treatment are without any significant
effect on the activity of the isolated product.

Both Beaton

-16et al• (1966b) and Kekwick and Pawan (1967) achieved some
purification of the material by ultrafiltration through Visking
dialysis membranes.

The greater portion of the activity was

found in the ultrafiltrate.
When the ultrafiltrate of the material from the urine of
fasting rats was further fractionated by passage through a Sephadex G-25 chromatographic column with elution with distilled
water, three active fractions were obtained (Beaton et al. 1966b)
These activities did not appear to
with protein.

~e

necessarily associated

The first active fraction coincided with the

presence of carbohydrate although in small amount.

The second

active fraction coincided with the presence of carbohydrate and
some protein.
protein.

The third active fraction was associated with

Consideration of t·hese observations immediately

raised the question about whether rat FMS contains three separate
fat-mobilizing substances or whether there is but one compound
attached to or absorbed by different carrier substances.

The

answer to this question has not yet been secured.
When the ultrafiltrate of the material from the urine of
fasting humans was further fractionated by

pas~age

through a

column of Sephadex G-50 and then through a column of Bio-Gel
P-10, a reasonably homogeneous extract was obtained which gives
a single band when subjected to electrophoresis on polyacrylamide gel (Kekwick and Pawan, 1967, Pawan, 1971).
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Chemical Nature _of FMS
Chalmers et al. (1960a)

desc~ibed

the Fat-Mobilizing

Material they had obtained from the urine of fasting humans as
a polypeptide with molecular weight less than 18,000.

It con-

tained about 8% nitrogen and after acid hydrolysis, it yielded
the following amino acids1 histidine, phenylalanine, leucine,
serine, cystine, aspartic acid and a trace of alanine.
a weak Molisch test for carbohydrate.

The biological activity

was thermostable up to 80°C in 0.1 N sodium hydroxide.
destroyed by boiling for two minutes.

It gave

It was

Activity was completely

destroyed by digestion with trypsin and chymotrypsin but some
activity remained after peptic digestion.
Unpurified fat-mobilizing substance from rat urine was
reported to contain several amino acids in addition to those
listed by Chalmers et al. (Beaton et al. 1964).

The nitrogen

contents of human and rat FMS are essentially the same (Beaton
et al. 1964).

Carbohydrate is also nresent irt n,..."!1urified FMS

obtained from rat urine (Beaton et al. 1964).
Seifter et al. (1968) after studying the lipid mobilizing
peptides from various sources suggested that al_l lipid mobilizing
peptides reported since 1956 are closely related chemically.
Many questions concerning FMS cannot be answered until it can be
isolated in pure form.

-18STATEI1IENT OF THE PROBLEM

-

The sequence of events following injection of FMS into

susceptible animals involvess (1) rise in the concentration of
free fatty acids within adipose tissue; (2) discharge of these
acids into the blood, with resultant increase in plasma concentration of free fatty acids which circulate as albumin-free
fatty acid complexes and (J) uptake and reesterification of a
proportion of the newly mobilized, circulating free fatty acids
by liver with resultant fatty liver.
Most in vivo and in vitro studies on FMS have been focused
on these aspects and a general agreement has now been reached
that the primary action of FMS is to increase the concentration
of free fatty acids within the fat cells, representing an
acceleration of lipolysis and not a suppression of reesterification.

Little is known, however, about how FMS acts on fat cells

to cause this response.
Reports from many laboratories have shown that adipokinet1c peptides increase the cellular concentration of free
fatty acids by virtue of activating a "hormone-sensitive"
lipase within the fat cells thereby accelerating lipolysis
(Hollenberg et al. 1961, Rizack, 1961, Vaughan et al. 1964).
Rizack (1964,1965) reported that cyclic AMP in the presence of
ATP and Mg 2+ would 1 arge 1 y res t ore th e "h ormone-sens~· t ~ve
· "
lipase activity which had previously been inactivated by
incubation of fat pads for J hours prior to homogenization.

-19It is now generally accepted that cyclic
in

hormon~

~~p

plays a key role

regulation of lipid mobilization (Vaughan, 1961,

Klainer et al. 1962, Butcher et al. 1965, Mosinger et al. 1969,
and Tsai et al. 1970).
It is the purpose of this dissertation to further purify
this lipolytic factor, to characterize some. of its chemical
and biological properties, to investigate the influence of
various factors which may affect its urinary excretion and its

-in vitro response

to adipose tissue and to study the role of

.

cyclic AMP as a mediator in lipolysis stimulated by FMS.

It

is hoped through these means to provide a better understanding
of the nature and mechanism of action of this biologically
active principle.

CHAPTER II
MATERIAL AND METHODS

GENERAL EXPERIMENTAL PROCEDURES

-

In the first part of this work, .the main purpose was to

develop_a condition under which maximum amount of crude
could be obtained per 24 hr. urine collection.

F~~

Thus adult

male albino rats were fed different diets, exposed to different
environmental temperatures and fasted for various periods of time
prior to urine collection.

The conditions under which maximum

yield of crude FMS was obtained were ·then utilized in the
development of the isolation procedure.

Crude FMS was extracted

from the urine by a three-stage processa (1) benzoic acid
· precipitation at pH 5.3; (2) extraction of FMS from the precipitate with distilled waterr (J) alcoholic precipitation at
pH 5·3·

The alcoholic precipitate was lyophilized after solution

in distilled water.
At this stage, FMS was assayed in vitro by incubation with
epididymal fat pads from male rats in a Krebs-Ringer phosphate
buffer, pH 7.3, containing 4% bovine serum albumin.

The in-

creased release of free fatty acids into the medium was taken
as the index of lipolytic activity.
difficulties initially.

This sometimes presented

This may be due to the presence of inhi-

bitory substances that interfered with the assay procedure as

-21-

indicated by Pawan (1971).
r

It may be due to the inconsistent

lipolytic response of adipose tissue to FMS.

f

In an attempt to improve the biological assay, epididymal
fat pads from animals fed different diets, fasted for various
period of time and subjected to a cold enviromental temperature
were tested for in vitro lipolytic response to FMS and the
conditions under which maximum response were exhibited, were
incorporated into an in vitro bioassay procedure.
Crude FMS was then partially purified by ultrafilt:t;'ation
with PM-10 and m1-2 Diaflo membranes and then further fractionated by passage through Sephadex G-50 and BioGel P-10 Chromatographic columns with elution with distilled water.

The trans-

mission of the effluent at 280 nm was monitored with a Uvicord
absorptiometer and recorder and fractions were collected with
a Savant Fraction Collector.

Each fraction was assayed in vitro

for lipolytic activity and the active fractions were pooled and
lyophilized.

The ·homogeneity of the material obtained at each

attempted stage of purification was examined by electrophoresis
utilizing cellulose acetate membranes as well as polyacrylamide
gel.
Once purified FMS was at hand, the study of the role of
cyclic AMP in lipolysis stimulated by FMS was initiated.

In

this part of the investigation, labeled adipose tissue cells
were prepared and incubated with FMS and method for assaying
the accumulation of cyclic AMP in isolated fat cells previously

-22labeled with tritiated adenine was utilized.

In this assay

procedure, cyclic AMP is purified from undesired labeled
nucleotides by barium sulfate treatment and the radioactivity
in the barium sulfate supernatant is measured by liquid scintillation in a Beckman LS 250 Liquid Scintillation Spectrometer.
rn order to ensure that the radioactivity measured represented
cyclic

~JP

exclusively, the barium sulfate supernatants were

examined chromatographically.
By use of the above procedures, the mechanism by which
FMS augments the lipolytic reaction in rat adipose tissue was
studied in light of the current theory that lipolytic hormones
utilize cyclic AMP as a second messenger to promote the activity
of hormone-sensitive lipase.
CHEMICALS
Acrylamide, Eastman Organic Chemicals, No. 5521
'Adenine (3H(G)J, 5-15 Ci/mmole, Lot No. 640-126, New England
Nuclear
Adenosine 3',5'-Monophosphate, Sigma Chemical Company, No. A9501
Albumin, Bovine, Fraction V Powder, Sigma Chemical Company,
No. A4503
Alcohol, 95%, Commercial Solvents Corporation
Alcohol, Absolute, Commercial Solvents Corporation
Ammonium Hydroxide, Mallinckrodt Chemical Works, AR, No. 3256

l

-2.3Barbital buffer, Beckman Instruments, Inq., No • .320024
Barium Hydroxide.8H 20, Mallinckrodt Chemical Works, AR, No • .3772
Benzoic Acid, Aldrich Chemical Company, No. 10,947-9
Bio-Gel P-10, 50-100 mesh, Bio-Rad Laboratories, No. 81102
Bio-Solv BBS-J, Beckman Instruments, Inc., No. 18498.3
BIS (N, N'-Methylene-bisacrylamide), Eastman Organic Chemicals
No. P 8.38.3
Bromphenol Blue (Water Soluble), Hartman-Leddon Company, No.
859
Calcium Chloride, Anhydrous, Mallinckrodt Chemical Works, AR
No. 41.32
Casein, Nutritional.Biochemicals Corporation
Chloroform, Mallinckrodt Chemical Works, AR, No. 4440
Collagenase, Type III, Fraction A, Sigma Chemical Company,
No. C-0255
Coomassie Brilliant Blue

R-250~

Colab Laboratories, Inc., No.

ll-152B
Copper Suifate.5H 2o, Mallinckrodt Chemical Works, AR, No. 4844
Crisco, Procter and Gamble Company
Cupric Nitrate. JH 2o, Fisher Scientific Company_, No. 7.3205
1, 5 Diphenylcarbohydrazide, Eastman Kodak Company, No. 618
Fiber, Non-nutritive, Nutritional Biochemicals Corporation
Fixative Dye Solution, Beckman Instruments, Inc., No. J24J40
Glycine (Ammonia Free), Eastman Organic Chemicals, No. 445

-24Glycerine, Fisher Scientific Company, CR, No. G33
~,

Heptane, Eastman Organic Chemicals, No. 2215
Hexane, Aldrich Chemical Company, No. 13,938-6
Hydrochloric Acid, J.T. Baker Chemical Company, No. 9535
Isopropyl Alcohol, Mallinckrodt Chemical Works, AR, No. 3032
Liver Powder, Nutritional Biochemicals Corporation
Magnesium Sulfate.7H 20, Mallinckrodt Chemical Works, AR, No. 605t
Methanol, Anhydrous, Mallinckrodt Chemical Works, AR, No. 3004
Palmitic Acid, Sigma Chemical Company, No. P-0500
PPO (2,5-Diphenyloxazole), Beckman-Instruments, Inc., No. 161692
Potassium Chloride, Granular, Mallinckrodt Chemical Works, AR,
No. 6858
Potassium Ferricyanide, Sargent-Welch Scientific Company, AR,
No. 14180
Riboflavin, Eastman Organic Chemicals, No. 5181 Salt Mix, Wesson Modified Osborne-Mendel, General Biochemicals,
No. 170900
Sephadex G-50, Medium, Pharmacia Fine Chemicals Inc.
Siliclad, Clay Adams Company
Sodium Carbonate, Anhydrous, Mallinckrodt Chemical Works, AR,
No. 7521
Sodium Chloride, Mallinckrodt Chemical Works, AR, No. 7581
Sodium Hydroxide, Pellets, Mallinckrodt Chemical Works, AR,
No. 7708

-25Sodium Phosphate Dibasic, Anhydrous, Mallinckrodt Chemical
Works, AR, No. 7917
Sucrose, Nutritional Biochemicals Corporation
Sulfuric Acid, Mallinckrodt Chemical Works, AR, No. 2876
TElfiliD (N, N, N' ,N'-Tetramethylethylenediamine), Eastman Organic
Chemicals, No. 8178
Theophylline, Crystalline, Sigma Chemical Company, No. T-1633
Thymol, Aldrich Chemical Company, No. 11,209-7
Toluene, Mallinckrodt Chemical Works, AR, No. 8608
Trichloroacetic Acid, Mallinckrodt Chemical Works, AR, No. 2928
TRIZMA-Base, Sigma Chemical Company, No. T 1503
TRIZIVIA-HCl, Sigma Chemical Company, No. T 3253
Triethanolamine, Eastman Organic Chemicals, No. 1599
Trypsin, Type III, from Bovine Pancreas, Sigma Chemical Company
No. T-8253
Trypsin Inhibitor, Type II-0, from Ovomucoid (Egg White), Sigma
Chemical Company, No. T-9253
Vitamin Diet Fortification Mixture, Nutritional Biochemicals
Corporation
Zinc Sulfate.7H 2 o, J.T. Baker Chemical Company, No.4382
EXTRACTION OF CRUDE FMS FROM RAT URINE
Thirty-day old male albino rats were purchased from Loc6k
Erickson Laboratories, Maywood, Illinois.
•
r

l

Crude FMS was ex- ·

-26tracted from the urine of these rats according to the method of
~

Beaton et al. (1964).

S·3

with N HCl.

The pH of the rat urine was adjusted to

10 volumes of a saturated solution of benzoic

acid in 95% ethanol was slowly added to each 100 volumes of urine
with constant stirring.

Following thorough mixing for 15

minutes, precipitation was allowed to proce~d overnight at 4°C.

in a stoppered container.

The bulky precipitate which formed

served to adsorb and coprecipitate FMS from the urine.

The

precipitate was then centrifuged at 15,000 x g at 0° to 5°C.

in an International Model PR-2 centrifuge and the supernatant
fluid discarded.
In order to

r~move

the benzoic acid, the precipitate

was washed twice in large centrifuge tubes with cold 95% ethanol
at pH 5.3, using a glass rod to break up any lumps and mixing
thoroughly.

The ethanolic washings were discarded on each

occasion after centrifugation.
FMS was then eluted from the precipitate by adding 100
ml of distilled water, mixing thoroughly over a period of about
15 minutes and using a glass rod to break up any lumps.
aqueous solution was then centrifuged and the

~upernatant

The
retain-

ed.
Reprecipitation of FMS was then carried out by adjusting
the aqueous solution to pH 5·3 with N NaOH or N HCl as required
and slowly adding 2 volumes of absolute alcohol while constantly

-27stirring with magnetic stirrer.
.

The suspension was left in the cold (4

0

0

to 10 C.) for

the next 24 hrs in a stoppered container for precipitation to

be completed.

The suspension was next centrifuged and the

supernatant was discarded.

To the

r~sidue,

50 ml of distilled

water was added, the slurry was mixed thoroughly and left for
1.5 minutes to dissolve the FMS.

After centrifugation, the

supernatant solution was lyophilized.

The lyophilized product

(crude FMS) was kept in the refrige:rator in a tightly-stoppered
container.

IN VITRO BIOASSAY OF FMS
The biological activity of FMS was measured by its abili
to increase the release of free fatty acids (FFA) in vitro
from epididymal fat pads of the rat in a medium of Krebs-Ringer
phosphate butfer (pH 7.4) containing 4% bovine serum albumin.
The amount of FFA released to

th~

medium was determined by the

method of Duncombe (1964), with modifications.

In this assay,

chloroform soluble copper soaps of the FFA are formed and the
chloroform soluble copper is converted to a co.lored complex by
treatment with 1,.5 diphenylcarbohydrazide.
Reagents
1M Triethanolamine•

14.9

gm

of triethanolamine was dissolved

in distilled water and diluted to 100 ml with distilled water.

-28-

i·45%

3 2

2

Cu(NQ ) ~ oa

6.45 grn of cupric nitrate trihydrate

was dissolved in distilled water and diluted to 100 ml with
distilled water.
1 ,5 Diphenylcarbohydrazide Solutiona 0.5 gm of 1,5 diphenylcarbohydrazide was dissolved in methanol and the volume was made

-

·up to 100 ml with methanol.

This solution should be prepared

just prior to the final steps.of the assay as aging of this
reagent resulted in increased blank values.
Copper Reagent:

A mixture of equal volumes of 1 M triethanol-

amine and 6.45% cupric nitrate trihydrate solution
Standard Fatty Acid Solution:

Standard solutions of palmitic

acid ranging from 20 to 120 uM in chloroform were prepared.
Krebs-Ringer Phosphate Buffer (pH ?.4) Containing 4% Albumina
Krebs-Ringer phosphate buffer containing the following components
NaCl, 128 mM; Mgso 4 , 1.4 mM; CaC1 2 , 1.4 mM; KCl,
5.2 ~~ and Na 2HPo , 10 mM. The phosphate buffer was made
4
up fresh daily and the pH adjusted to 7,4 after addition of

was prepared:

sufficient bovine albumin to yield a 4% (w/v) solution.
Preparation of Standard Curve
Approximately 5 ml of standard palmitic acid solutions
were placed in 18 x 150 mm glass tubes.

The solutions were mix-

ed thoroughly with 2.5 ml of copper reagent for 30 seconds
using a Vortex mixer set at top speed.

The two layers were

allowed to separate and approximately 4 ml of the chloroform
layer was removed with a 6" , 18 gauge needle and syringe and

-29~fm5ferred to another

is

x 150 mm tube, care being taken not to

any of the copper solution.

About 2 ml of water was

the top of the chloroform without mixing.

The tubes

centrifuged in a clinical centrifuge set at top speed for
1o minutes. The aqueous layer was completely removed along with
-asmall amount of chloroform layer, with a disposable pipet.
ThiS step was to insure that any small amount of copper reagent
remaining in the chloroform layer was removed.

Aliquots of

..

1.0 ml of the chloroform solution of the soap were pipetted into

5 ml volumetric flasks.

1.0 ml of complexing agent, 1,5 diphenyl

carbohydrazide, was added and the mixtUre was diluted to volume
with chloroform.

The absorbance of each solution at 540 nm was

read in a Beckman DU Spectrophotometer exactly 5 minutes after
the addition of the complexing agent.
ard curve appear in Table 1.

The data for this stand-

A linear relationship between the

absorbance at 540 nm and the concentration of palmitic acid
within the range of 4 to 24

uM

is shown in Figure 1.

Determination of the Biological Activity of

Fr~

An epididymal fat pad weighing 250 mg was placed in a

25 ml Erlenmeyer flask containing 5 ml of Krebs-Ringer phosphate
buffer with 4% albumin.

After the addition of 100 ugm of

mv~

(or of a test material) the flask was incubated for 3 hours at
37°0 in a Dubnoff Metabolic Shaker using air as the gas phase.

At the end of the incubation, 1.0 ml of the mixture was

-JO-

Table 1

Standard Curve Data for Determination of Free Fatty Acids

Palmitic Acid, YM

No.
of
Determinations

Absorbance 540nm*

4

.6

8

6

0.167 + 0.017

12

6

0.295 :!: O.OlJ

16

6

20

6

24

6

± 0.027
0.555 ± 0.029
0.680 ± 0.02J

*Mean ± standard deviation

O.OJ6

0.425

.:!:

0.047
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Standard curve for determination of free
fatty acids·

-32diluted with 1 ml. of distilled water and extracted in a 18 x
~

15 o mm glass-stoppered centrifuged tube with 5.0 ml. of chloroform by mixing for 1 minute on a Vortex mixer set at top speed.
The mixture was centrifuged in a clinical centrifuge for 20
minutes.

The aqueous and chloroform layers were separated by

a disc of precipitated protein.

3 ml. of the chloroform solution

were pipetted into a clean dry tube and analyzed for free fatty
acids.

The concentration of the FFA ·in the medium was calculated

from the regression line equation of absorbance versus concentration determined by the method of least squares, namely F 31.06A + 2.82 where F represents the uM concentration of FFA and
A, the absorbance value.

The total FFA released to the medium

as umoles was calculated by multiplying the value of F by the
dilution factor.

PURIFICATION OF CRUDE FiviS BY ULTRAFILTRATION
A

0.5% aqueous solution of crude FMS was transferred to

an Amicon Ultrafiltration Cell, Model 52, fitted with a PM-10
Diaflo membrane.

A pressure of 10 psi was applied and the cell

was stirred at relatively high rate.

Ultrafiltration was allow-

ed to proceed for about 1.5 hours at an environmental temperature of 0° to

5°C.

During this time, .more than 50% of the fluid

passed through the ultrafilter.

The ultrafiltrate and the

residue were freeze-dried and bioassayed in vitro for lipolytic

-33activity.
The biologically active fraction was then subjected to
ultrafiltration in a like manner using a UM-2 Diaflo membrane.

~PHADEX

G- SO AND BIO-GEL P-10 FRACTIONATION OF' FMS

A 0.01% aqueous solution of the biologically active fract
ion from the ultrafiltration with the UM-2 membrane was passed
through a prepared column (K 25/45 jacked, Pharmacia Fine
Chemicals Inc., Piscataway, N.J.) of Sephadex G-50 and then
through a column of Bio-Gel P-10.

The temperature of the

columns was maintained at 0° to 5°C.

Elution with distilled

water was carried out at a rate of 2.5 ml. per minute and serial
fractions 5 ml. in volume were collected with a Unifrac Fraction
Collector (Savant Instruments Inc., Hicksville, New York).

The

transmission of the effluent at 280 nm was monitored with a
Uvicord Absorptiometer and Recorder (LKB Instruments Inc.,
Rockville, Maryland).
( 100 ·tubes) •

Every fourth tube was bioassayed in vitro for

lipolytic activity.
lyophilized.

The total volume of eluate was 500 ml.

The active fractions were pooled and

A diagram of the scheme for the extraction and

purification of FMS is shown in Figure 2.

MICROZONE ELECTROPHORESIS OF FMS PREPARATIONS
Reagents a
Buffer Solution (pH 8.6)a

One package of Beckman barbital
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Urine from Fasting

I

Benzol c

Rats

pH 8.3
Benzoic Acid

Acid

Precipitate

3X . Ethanol
wash

1

Residue

I

Distilled Water

Water

Soluble

I
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I

I
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I
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Figure 2.

Flow diagram for isolation and purification
of FMS.

-35buffer was dissolved in warm distilled water.

After being cooled

to room temperature, the buffer solution was diluted to one
liter with distilled water.
fixative-Dye Solution:

The contents of a 30-ml bottle of Beck-

man Fixative-Dye Solution was diluted to 250 ml with distilled
water.
Acetic Acid Rinse Solution•

Jy.

5% (v/v) solution of acetic acid

was prepared by diluting 5 ml of glacial acetic aciQ to 100 ml
with distilled water.
Clearing Solution:

A 25% (v/v) solution of acetic acid in 95%

ethyl alcohol was prepared by diluting 25 ml of glacial acetic
acid to 100 ml with ethyl alcohol.

This solution must be mixed

fresh with each filling of the tray.
Alcohol Rinse Solutiona
Procedure:

95% ethyl

a~cohol

The membrane strip (Beckman Instruments, Inc., Cata-

log No. 324330) was first impregnated by floating on the surface
of, prior to immersion into, the buffer solution.

In order to

remove the excess of buffer, the membrane strip was gently
pressed between two blotters.

It was then clamped onto the

bridge of the Microzone tank (Beckman Instruments, Inc., Model
R-101) filled to the mark with the buffer solution.

The bridge

was inserted, the lid attached and the plug was connected to
the tank.

FMS preparations previously dissolved in distilled

water, were applied ontothe strip with a sample applicator.
The tank was closed with the covering plate.

Electrophoresis

-36was carried out for JO minutes at a constant voltage of 250
volts.
After the electrophoretic run, the strip was placed in
the fixative-dye solution for 5 minutes and then exposed to
the acetic acid rinse solution until completely destained.
The strip was then placed in the alcohol rinse solution for

3 to 5 minutes.

It was then placed in the clearing solution

for another 15 minutes.

By using the rubber wiper, the pre-

parate was firmly fitted onto a glass plate free from air
bubbles and then placed in a 100°C oven for 10 minutes to dry
the membrane.
After the glass plate had cooled to room temperature, the
membrane was peeled off and inserted into a plastic storage
envelop for scanning and storage.

GEL ELECTROPHORESIS OF FMS PREPARATIONS
The polyacrylamide gel electrophoresis unit manufactured
by the Hoefer Scientific Instruments Company, San Francisco,
California was utilized.
Reagents a
Stock Solutionsa

All stock solutions were prepared using de-

ionized water and they were stored in brown bottles in the
refrigerator.

Most of these stock solutions have a shelf-life

of up to three months.
Solution Aa

J6.J gm of TRIZMA-base and 0.46 ml of

TE~ffiD

were

-37dissolved in approximately 40 ml of N HCl and the pH of the
solution was adjusted to 8.9 by titrating with N HCl.

Deionized

water was added to bring up to the volume of 100 ml.
§plution Ea

5.98 gm of TRIZMA-base and 0.46 ml of TEMED were

dissolved in approximately 40 ml of N HCl.

The pH of the

solution was adjusted to 6.7 by titrating with N HCl and the
solution was diluted to 100 ml with deionized water.
Solution C:

JO.O

gm

of acrylamide, 0.8 gm of ""BIS and 0.015 gm

of potassium ferricyanide were dissolved in deionized water and
diluted to 100 ml.
Solution Dr

10.0 gm of acrylamide and 2.5 gm of BIS were

dissolved in deionized water and diluted to 100 ml.
Solution Ea 0.14 gm of ammonium

pers~lfate

was dissolved in

deionized water and diluted to 100 ml.
Solution F:

0.004

gm

of riboflavin was dissolved in deionized

water and diluted to 100 ml.
101o TCA Solutions

100 gm of trichloroacetic acid was dissolved

in deionized water and diluted to one liter.
Coomassie Brilliant Blue Stock Solution;

1 gm of Coomassie

Brilliant Blue was suspended in 100 ml of deionized water and
the solution was stirred and filtered through Whatman No. 1
filter paper.
Coomassie Brilliant Blue Working Solutiona

1 ml of Coomassie

Brilliant Blue stock solution was diluted to 20 ml with 10%
TCA solution.

-38§g]aration Gel Solutions

c,

2 ml of Solution A, 4 ml of Solution

8 ml of Solution E and 2 ml of deionized water were placed

in separate flasks and allowed to warm up to room temperature.
These four components were then added to a single flask and
swirled gently to prevent air bubble formation and to provide
th.orough mixing.
~tacking

and Sample Gel Solution:

2 ml of Solution B, 4 ml of

Solution D, 2 ml of Solution F and 8 ml of deionized water
were placed in another set of small flasks.

These solutions

were warmed to room temperature and gently mixed in a flask that
was completely wrapped in foil to protect this gel solution
from premature photopolymerization.
Procedure:

Twelve acid-cleaned Pyrex glass columns (6.5 em

long and having an inner diameter of

0.5 em and an outer dia-

meter of 0.7 em) and previously coated with a wetting agent
(e.g. 1 part Kodak Photo-Flo to 200 parts of water) were placed
in column base caps (vacutainer tops).

The gel columns were the

placed into a loading rack in which front-to-back vertical
aligment of the gels could be assured.
With the use of a 1 ml tuberculin syringe, to which a

·5 em length of Tygon tubing was attached, exactly 0.8 ml of
the separation gel solution was dispensed into each of the
twelve vertical gel columns.

Then with an Oxford pipette, 100

ul of water was carefully layered on top of the gel solution.
If the gel column had not been coated with a wetting agent

prior to use, a bolus of water would form which would drop into
the gel solution and dilute it.

If the gel columns are coated,

water will layer evenly on top of the unpolymerized gel solutions.
The purpose of the water layering of the gel solution is to
prevent a gel-air meniscus and to produce a flat gel surface
which is highly important for obtaining good protein band
formation.

It also prevents oxygen which retards gel formation

from diffusing into the gels.
The separation gels were undisturbed for one half pour
during which time complete chemical polymerization occurred
as was evident by the visibility of a distinct refractile line
between the gel and water

interface~

The columns were then removed from the loading rack and
the water layer was removed by giving the gel column a quick
flick of the wrist.

The lip of the gel column was then touched

to a piece of absorbent paper to remove the last traces of
water.
Exactly 0.2 ml of stacking and sample gel solution was
added to each gel column, with the use of a 1 ml syringe as
before.

Once again, 100 ul of water was layered over this

gel solution as previously described.

The entire loading rack

was then positioned approximately 30 em from a fluorescent
light source for

15 minutes; at that time photopolymerization

began as evidenced by the appearance of opalescence in the

-40stacking gel.
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When photopolymerization had begun, the light

source was moved to about 5 em from the columns and photopolymerization was completed in another 15 minutes.

The water

layer was then removed as previously described.
Exactly 1.5 mg of the FMS preparation to be tested was
dissolved in 1.0 ml of the stacking and sample gel solution and
0.2 ml of the solution was added on top of the stacking gel
•

and layered with 100 ul of water.

The sample gel was allowed

to photopolymerize for 30 minutes while positioned 5 em from
the fluorescent light.
The gel columns were then removed from the loading rack
and carefully inserted into the holes of the upper bath stoppers
{sample gel uppermost).

Buffer solution was then added on

top of the sample gels and to. the separation gels such that a
hanging drop of buffer remained at the bottom of all gel
columns.

It is essential that no air bubbles are entrapped in

the gel columns.
·The lower bath {containing the anode) of the Hoefer
apparatus was then filled with 1000 ml of buffer and the upper
bath assembly was then carefully placed into position making
sure that no air bubbles were entrapped at either ends of the
gel columns.

The upper reservoir was then filled with 500 ml

of buffer solution and 3 to 5 drops of 0.005% bromphenol blue
was added to serve as a tracking dye.
The lid was placed on the upper bath and a current of
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mA (J.O rnA per gel) was applied.

Electrophoresis was carried

out until the front of the now discrete tracking dye had
to approximately 1/4 inch from the end of the separation

At the completion of electrophoresis, the gel columns
were removed from the upper reservoir and immersed in ice-cold
water for 5 minutes to allow maximal gel contraction.

The con-

tracted gel was removed from each column by inserting an 18
gauge needle, attached to a 10 ml syringe filled with ice-cold
water, between the glass-column and the sample gel while
rotating the gel column with one hand and injecting water around
the gel surface with. the other.

The water pressure freed the

stacking and separating gels and in a few moments the intact
gel was expelled from the se-parating gel end of the glass
column.
The gels were quickly placed in a 10% solution of TCA
for a minimum of one hour to insure that the protein fractions
were uniformly fixed.

The gels were then stained by immersion

into 20 ml of the Coomassie Brilliant Blue working solution
for another hour.

Destaining of gels was done by three conse-

cutive immersions of the gels into 10% TCA solution, each immersion lasting about an hour.

When the section of a gel,

containing no separated fraction was completely clear of stain,
the gel was transferred to a solution comprised of equal parts

r

r
-42of glycerol and deionized water.

This solution allows for the

storing of the gels without shrinkage.
Unstained gels obtained from the electrophoretic run
on purified FivlS were examined for lipolytic activity by cutting
the protein segment of each gel.

The segments were pooled and

homogenized in 10 ml of distilled water.

The suspension was

then centrifuged at 20,000 x g for 10 minutes.

The supernatant

was decanted and the homogenized gels were washed three times
with 5 ml portions of water.

The washings and the supernatant

were combined and lyophilized and the lyophilized product was
assayed in vitro for lipolytic activity.

PREPARATION OF ISOLATED FAT CELLS LABELED WITH TRITIATED ADENINE
Isolated adipose cells labeled with tritiated adenine
were prepared according to the procedure of Rodbell (1964) as
modified by Kuo and DeRenzo (1969) and Moskowitz and Fain (1970).
Method1

10 to 15.gm of rat epididymal fat pads were incubated

for 1.5 hrs. at 37°C with shaking in a 25 ml siliconized flask
containing 10 ml of Krebs-Ringer phosphate buffer, pH 7.4 with

4% (w/V) bovine serum albumin and 10 uCi of adenine-3H (G).
An additional 10 to 20 uCi of adenine-3H (G) were then added
to the incubation mixture together with 7 mg of collagenase
and 4 mg of crystalline trypsin.

Cells were isolated by

digestion with trypsin in addition to collagenase in order to
diminish the effect of insulin or "insulin-like" substances on

-43the response to lipolytic agents.
in about another 40 minutes.

The digestion was completed

The whole digest was then trans-

ferred to a polyethylene centrifuge tube containing 10 ml of
warm (37°C) albumin-phosphate buffer.

Fat cells were liberated

from the tissue fragments by gentle stirring with a siliconized
·glass rod.

Liberation of cells was manifested by an increased

turbidity of the medium.

Fra&ments of tissue still remaining

after this treatment were removed with forceps.

The. suspended

cells were centrifuged for 1 minute at 400 x g.

The fat cells

floated to the surface and the stromal-vascular cells were
sedimented.

Fat droplets, which were formed from the breakage

of the fat cells, floated more rapidly to the surface than the
fat cells and were aspirated from the surface, after gentle
stirring the cell suspension.

The stromal-vascular cells were

removed by aspiratinn and the adipocytes were washed by

suspendin~:>

in 10 ml of warm albumin-phosphate buffer and centrifuged for
1 minute at 400 x g.

The washing procedure was repeated three

times· in order to insure removal of stromal-vascular cells and
excess tritiated adenine.

The cells were finally resuspended

in an appropriate volume of albumin-phosphate buffer containing
0.1 mg per ml of trypsin inhibitor to give a cell concentration

equivalent to 250 mg (wet weight) of epididymal fat pads per
ml.
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INCUBATION OF LABELED FAT CELLS WITH LIPOLYTIC AGENTS AND ASSAY

- .......OF CYCLIC AI...:i.P

Labeled adipose cells were incubated with lipolytic
agents and the accumulation of the cyclic AMP in the medium was
determined according to the procedure of Krishna et al. (1968).

in

this assay procedure, labeled cyclic AMP was purified by

addition of zinc sulfate and

b~ium

all the undesired nucleotides.

hydroxide to precipitate

The radioactivity in

~he

barium

sulfate supernatant was determined.
Reagen"t,~s

Dole's Solution

40 parts of isopropyl alcohol, 10 parts of

hexane and 1 part of N H2so 4 were shaken in a 250 ml separatory
funnel and allowed to come to equilibrium.
5% Zinc Sulfate Solution

5

gm of Zin9 Sulfate.7H2o were dis-

solved in 100 ml of distilled water.
Barium Hydroxide.8H 2o
was added to boiling water until the solution was well saturated.

Saturated Barium Hydroxide Solution

The hot solution was filtered through Whatman No. 1 paper, when
crystal growth was noticed on cooling.
Procedure&

1 ml of fat cell suspension was transferred to a

plastic tube (17xl00 mm) containing 4 ml of fresh medium with
control or experimental additions and incubated for the desired
time at 37°C in a Dubnoff metabolic shaker using air as the
gas phase.

The incubation was terminated by extraction of the

-45reaction mixture with 2 ml of Dole's solution, followed by 2 ml
of hexane (Moskowitz and Fain, 1970).

The organic and the

aqueous layers were separated in a 30 ml separatory funnel.
A portion (1.0 ml) of the organic layer was taken for the
determination of free fatty acids released to the medium and
the aqueous layer was collected in a clean 25 ml flask and placed
in a vacuum oven (Thelco,

Prec~sion

Scientific Company, Chicago,

Illinois) for 20 minutes at room temperature to remove residual
organic solvents.

The protein precipitated in the aqueous

layer was removed by centrifugation. .5 ml of the clear supernatant were taken and the labeled cyclic

~~P

was purified by

the addition of 1.0 ml of 5% Zinc Sulfate and 0.3 ml of saturated
barium hydroxide solution to precipitate all the undesired
nucleotides (Krishna et al. 1968).

Tne slurry was centrifuged

and the supernatant was removed for the determination of
radioactivity.

LIQUID·. SCINTILLATION COUNTING

0.2 ml aliquot of the BaSo4 supernatant was placed in
a liquid scintillation counting vial and to this was added 10
A

ml of a toluene-base counting solution.

This scintillation

solution was prepared by dissolving 5 gm of PPO in one liter
of toluene and to every 100 ml of this solution was added 20
ml of the Beckman solubilizing reagent Bio-Solv BBS-J.

The

-46samPl~were

counted in a Beckman LS-250 Liquid Scintillation

Spectrometer using the automatic quech correction function (AQC).
A quench correction curve was prepared by adding various amounts
of cyclic AiviP extracted from isolated fat cells, which had been
incubated with lipolytic agent and purified by BaS04 precipitat10 ml of the toluene fluor containing 105,600 dpm of
toluene per vial.

These samples were counted with the

Liquid Scintillation Spectrometer using the automatic
correction.

The per cent efficiency was plotted against

the external standard ratio (Figure

J).

These data were

utilized to express the radioactivity measurements in terms of
disintegrations per minute.
CHROMATOGRAPHY
In order to insure that the radioactivity measured represented exclusively labeled cyclic AMP, the BaS04 supernatants
from various experimental runs were examined chromatographically.
The following solvent system was useda isopropyl alcohol, concentrated NH4 0H and water (7ala2). The BaS04 supernatants
were pooled and lyophilized and the dry material was taken
up in 0.5 ml of water.

0.1 ml aliquots together with 20 ugm

of unlabeled cyclic AMP as carrier, were spotted on strips of
1. 5 x 23" S

&

S No. 589 paper.

Descending chromatography

Was allowed to proceed for 14 hrs at room temperature.

After
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-48chromatograms at room temperature, the cyclic AMP
was located by ultraviolet light and the spot outlined with a
pencil·

The chromatograms were then cut into bands 0.5 em in

width and the radioactivity was counted in 10 ml of scintillation
liquid.
TRYPTIC DIGESTION OF FMS

-Reagents
o.o46 M Tris Buffers

0.557

gm

of TRIZMA-base and 0.1671

gm

of

cac1 .2H o were dissolved in 80 ml of ·distilled water. The pH
2
2
of the solution was adjusted to 8.1 and the volume was diluted
to 100 ml with distilled water.
Procedures

7•5 mg of FMS was dissolved in 2.0 ml of Tris Buffer

pH 8.1 containing 0.0115 M CaC1 2 •
0.3 mg of trypsin.

To'this solution was added

Incubation was carried out at 37°C for 4

hrs. and the reaction was stopped by addition of sufficient

li HCl to obtain a pH of 5.0.

As controls in this experiment,

trypsin and CaC1 2 (without FMS) were incubated.
Each digest was fractionated into substance greater and
less than 10,000 in molecular weight by use of a Diaflo ultrafiltration apparatus fitted with a PM-10 membrane (trypsin,
2),800; FMS less than 10,000).

The filtrate was further

ultrafiltered with a UM-05 membrane in order to remove salts
and then lyophilized.

Each product was tested for in vitro

-49lipolytic activity using epididymal fat pads.

CHAPTER I I I
EXPERUIENTAL RESULTS

The experimental portion of this dissertation consists
of three parts.

The first part deals with the extraction of

crude FMS with maximum yield from the urine of fasting rats and
the development of an in vitro bioassay procedure with maximum
sensitivity so that the identity of FMS can be established.

The

second part of this work comprises the purification of the crude
FMS and the determination of the homogeneity of each lipolytic
preparation.

The third part of the experimental work concerns

the mechanism by which FMS augments the lipolytic reaction in
rat adipose tissue.

This was studied in light of the current

theory that lipolytic agents utilize· cyclic AMP as a second
messenger to promote the activity of the hormone-sensitive
lipase.

Effect of Previous Dietary Regimen on the Excretion of FMS
Four groups of twenty-eight rats each, weighing from
400 to 450 gm were kept in individual metabolism cages at an·
environmental temperature of 24° + 1°C.

Each group was fed one

of the four isocaloric experimental diets shown in Table 2 for
a period of seven days.

The animals were then fasted for the

next 24 hrs during which time urine was collected and pooled

Table 2
Constituents and Caloric Content of Experimental Diets*

Constituent

Casein

High
Carbohydrate
Cals/g
~

18

0.69

High
Protein
~ Cals/g

64

2.46

Noncarbohydrate
High Fat
CalsL:g
~

18

0.69

High
Fat
2f Cals/g

18

0.69
I

68

2 .6}

10

0.39

-

-

10

0.39

Crisco

8

0.71

11

1.17

38

3·36

33

2.92

Non-Nutritive
Fiber
Salt Mixture

-

-

9

-

38

-

33

4

-

4

4

-

4

Liver Powder

2

-

2

-

2

-

2

100

4.03

100

Sucrose

Total

*Plus 2% vitamins,

4.02

100

4.05

100

4.00

VI.
1--'

I

-52for each group.

Crude FMS was extracted from the urine and

assayed in vitro for lipolytic activity.
From the data of Table 3, it is apparent that approximately equal amounts of crude FivlS were extracted by fasting
rats previously fed any one of the four diets ad libitum.
would appear that increased amount of

diet~ry

It

fat and decreased

amount of dietary carbohydrate are conducive to increased
excretion of FMS as judged by the increased release of free
fatty acids per rat.

The greatest excretion of FMS was observed

with animals fed diets providing a large proportion of calories
from fat.

Animals maintained on a high carbohydrate diet

excreted little or no FMS.

The specific activity of this

material was not significantly different from that of the
control ( p) 0. 40, paired Student t test).

This is in agree-

ment with the observation of Chalmers et al. (1960) that no
FMS could be detected in the urine of humans subsisting on a
calorically-restricted diet composed largely of carbohydrate.
The results of these experiments indicate that a positive
correlation exists between the lipolytic potency of the
material excreted and the proportion of calories from fat in
the diet.

These results support the observation of Beaton

et al. ( 1965) that the extraction of FMS is affected by the
nature of food prior to fasting.

-5.3Table .3
Effect of Previous Dietary Regimen on the Urinary
Excretion of Crude

Specific*
Activity

Diet

High
Carbohydrate
High
Fat
Noncarbohydrate
High Fat
High
Protein

I

F~~

mg/rat

Increased**
release of
FFA/rat,
umoles

J.81 ± 2.16

O.OJ

± 0.02*** i2. 5 ± 0.4

0.20

± 0.01

1).6 ± 2.1

27.60

± 6.20

0.19

± 0.02

12.9

± 1.9

24.82

± 5.68

0.11

± 0.02

14.2

± 0.9

15.76 ± .3·.35

*Increased release (umoles) of free fatty acids (FFA) as a
consequence of addition of 100 ugm of crude FN~ as compared
to release in the absence of F1~
**Calculated as specific activity x mg of material excreted
X 10
***Mean

± standard deviation on three separate urine collections
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28 male albino rats weighing 400-1.!- 50 grn were housed in
metabolism cages and fed a high-fat diet ad libitum.

After

seven days of this adaptation period at room temperature
(24° + 1°C), the rats were fasted for seventy-two hours at
room temperature.

At the end of each of tbree 24 hr. fasting

periods, urine was collected and pooled.
ed and bioassayed in vitro.

Crude FiviS was extract-

In addition, crude FMS was also

prepared from the urine of animals fed a high-fat diet but
not fasted.
It is apparent from Table 4 that crude FMS excreted by
fed rats had little lipolytic effect in vitro.

With fasting,

there was appreciable excretion of active FMS, the total
activity being greatest in the first 24 hr. fasting period and
diminishing thereafter.

The sudden increase of excreted acti-

vity may well be related to the coincident mobilization of
fat in these animals during fasting.

It has been often

observed that in situations in which the mobilization of fat
from depots is known to occur, there is an increased excretion
of FMS.

The decreased excretion of active FMS noted upon

prolonged fasting cannot fully be accounted for at this time.

-
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Duration of Fasting on Urinary Excretion of Crude FMS

Fasting
Period (hrs)

Fed

0 - 24

Specific*
Activity

Increased-l:·->~

mg/rat

release of
FFA/rat,
umoles

2.6) + 0.7

0.02 -+ 0. 02*-:~-~- 15.2 -+ 2.9
14.1 + 2.9
0.21 + 0.05

-

29.6 -+ 6.0

-

24 - 48

0.19 + O.OJ

10.9 -+ 4.4

20.7 -+ 8.4

48 - 72

0.20 -+ 0.02

6.4 -+ J.4

12.8 -+ 6.8

*Increased release (umoles) ·of free fatty acids (FFA) as a
consequence of addition of 100 ugm of crude FMS as compared
to release in the absence of FMS
**Calculated as specific activity x mg of material excreted
per rat X 10.
*-lH~Mean

:t standard deviation, three separate urine collections

yfect of Enviromental Temperature on Excretion of FMS
i

28 male albino rats weighing 400-450 gm were housed in
I

metabolism cages and fed a high-fat diet ad libitum.

After

seven days at room temperature (23 + 1°C), the rats were
fasted for 2L} hrs at each of the following enviromental
temperature:

5°, 10°, 15°, 25° and 30°C.

Urine was collected

during each fast, pooled for each group and crude FMS was
extracted and assayed in vitro.
As shown in Table 5, decreasing the enviromental temperature from 30° to 5°C resulted in an-initial progressive increased excretion of crude F.MS to a maximum at 15°C.

The

sudden and very marked increase in excretion of FMS at 15°C
is of considerable interest though the cause and significance
of this increase are not known.

It may well be that increased

spontaneous activity (exercise) or shivering is the causative
factor in increased excretion of FMS at about 15°C.

Exercise

has been reported-to increase serum concentration of free fatty
acids (Basu et al. 1960), an index of fat mobilization.

All

urine extracts possessed approximately equal specific lipolytic activity.

These results support the observations of

Braun and Mosinger (1961) and Stevenson et al. (1965) that a
fat-mobilizing material is excreted in the urine of rabbits
and rats respectively, when exposed to cold.
It is apparent from the results of these experiments

I

I

,I

I

I
I

:
I

-
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Effect of Environmental Temperature on Urinary
Excretion of Crude FMS

Increased~'*

Environmenta6
Temperature C

50

Specific·:<Activity

mg/rat

release of
FFA/rat,
umoles

±

0.18 + 0 • OJ'~HH'r

16.7 + 0.8

30.0

10°

0.21 -+ 0.05

27.4 -+ 0.8

57·5 + 0.6

15°

0.20 + 0.02

-

44.1 + 1.0

-

87.7 -+ 8.9

20°

0.19 -+ 0.03

16.4 + 0.8

31.1 + 0.2

30°

0.20 + 0.02

?.5+ 0.4

-

-

15.0 -+

0.2

1.4

-~~Increased

release ( umoles) of free fatty acids (FFA) as a
consequence of addition of 100 ugm of crude FiviS as compared
to release in the absence of FMS
**Calculated as specific activity x mg of material excreted
per rat x 10
***Mean + standard deviation, three separate urine collections

-58that the excretion of FMS is affected in quantity by the
enviromental temperature (Table 5).

In contrast, the quality

but not the quantity of FMS is affected by the nature of the
food fed prior to fasting (Table

J).

gjfect of Previous Diet on Lipolytic Response of Adipose Tissue
to FWS
In this experiment, the lipolYtic effect of FMS was tested on epididymal fat pads taken from thirty-day old rats previously treated with one of the following diets:

high carbo-

hydrate; noncarbohydrate, high fat; high fat and high protein
diets (Table 2).

After seven days on a given regimen, the

animals were fasted for twenty-four hours and then sacrified
to obtain the epididymal fat pads.
Lipolytic response of adipose tissue in the presence
and absence of FMS was determined and the results appear in
Table 6.

The results of these experiments demonstrated that

the previous dietary treatment of rats may alter the release
of free fatty acids by adipose tissue in vitro with the
absence or the presence of a lipolytic agent.

The release of

free fatty acids in the absence of FMS was essentially the same
with the tissue obtained from animals fed the high carbohydrate,
high fat and noncarbohydrate, high fat diets.

The release of

free fatty acids in the presence of FMS was greatest for adipose
tissues removed from animals previously fed high carbohydrate

-59Table 6
Effect of Previous Diet on Lipolytic Response of
Adipose Tissue to FMS

Diet

High
Carbohydrate

No addition,
FFA release

FMS (100 ugm)
Response*
FFA release

1.91

± 0.17**

3·71

± 0.18

1.80

± 0.16

High
Fat

2.06

± 0.12

3·57 ± 0.10

1.51

± 0.10

Noncarbohydrate
Fat
High

2.08

± 0.31

2.54

0.92

± 0.10

1.64 + 0.13

High
Protein

± 0.32

-

-

0.46 + 0.21
0.72

*Increased release (umoles) of free fatty acids (FFA) over
that observed in the absence of added FMS
**Mean

± standard deviation from six rats

± 0.11

-60and high fat diets.

Lipolytic response of adipose tissue to

FMS was greatest with previous feeding of high carbohydrate
diet and markedly decreased with the noncarbohydrate, high
fat diet and the high protein diets.

It is quite possible

that the response of adipose tissue in vitro to other lipolytic
agents may be similarly affected by the previous dietary regimen
of the donor animals.

The results of these experiments demon-

strated that for the bioassay of the lipolytic activity of
FMS, the use of epididymal adipose tissue from rats previously
maintained on a high carbohydrate diet is recommended.

Effect of the Fasting Period on Lipolytic Response of Adipose
Tissue to FMS
24

rats each weighing J00-400 gm were maintained on

a high carbohydrate diet for seven days.

At the end of that

time, six animals were killed and the remainder were deprived
of food and were sacrified six at a time after 24, 48 and
72 hours fastig.

Epididymal fat pads were removed and the

release of free fatty acids by them was
and absence of

FI~.

me~sured

in the presence

The results appear in Table 7•

The release of free fatty acids in vitro increased with
prolonged fasting in the presence and absence of FMS.

This

is probably related to the availability of L-o(-glycerophosphate
derived from glucose metabolism.

In the fed state,

-61Table 7
Effect of Fasting on Lipolytic Response of Adipose
Tissue to FMS

FMS (100 ug)
No addition,
FFA release

FFA release -

1.26 + 0.05**

1.64 + 0.20

0.38 + 0.29

24

1.J5 + 0.12

2.01 + o.4J

o.66 + 0.22

48

1.J9 + 0.08

2.55 + O.JO

lr16 + 0.05

72

2.50 + 0.10

. 4.87 + 0.39

2.37 + 0.09

Fasting
Period (hrs)

0

Response*

*Increased release (umoles) of .free fatty acids (FFA) over that
observed in the absence of added FMS
**Mean + standard deviation, six rats

-62adipose tissue metabolizes glucose (primarily derived from
r,

dietary carbohydrate) at high rate
amount of

L~-glycerophosphate.

1~-glycerophosphate

making available large

Adipose tissue utilizes the

and free fatty acids to generate trigly-

ceride so that free fatty acids are not released.

In the fasting

state, however, very little glucose metabolism occurs in the
adipose tissue and thus there.is little L-~-glycerophosphate
available for the formation of triglyceride resulting in a
net increase of lipolysis.

Beaton et al. (1966b) reported

that adipose tissue of fasted rats was much more responsive
to FMS than was that of fed rats.

This response can be almost

completely abolished by the addition of glucose.

The results

of these experiments were also supported by the observation of
Buckle and Beck (1962) that glucose added to the medium inhibits the lipolytic effect of growth

hormone, ACTH and

adrenal in.

Lipolytic Response to FMS of

Adipos~

Tissue taken from Rats

Exposed to Cold
In this experiment, twelve male albino rats weighing
250-350 gm were housed in metabolism cages and fed a high
carbohydrate diet ad libitum.

After seven days of this adapt-

ation period at room temperature, food was removed and the
animals were divided into two groups; a control group of six

-63rats was maintained at 24°C and a group of six rats was exposed
to an environmental temperature of 50 C.

Both groups of animals

were killed after seventy-two hours of fasting.

Epididymal

fat pads were removed from each and used for the bioassay of
F'MS.

The results given in Table 8 show that epididymal fat

pads taken from cold-exposed rats were

mor~

responsive to the

lipolytic action of FMS than were those taken from control
animals maintained at 24°C.

This is expected as fat mobilizatio

is known to occur when animals are exposed to the cold.

In

addition, previous experiments already demonstrated that excretion of FMS during fasting increases with lowering of environ
mental temperature.

Isolation and Purification of FMS
Thirty-day old male albino rats weighing 120-180 gm
were housed in suspended cages in an air-conditioned room.
animals were divided into two groups.

The

Thirty rats in one

group were provided a high fat diet (Table 2) and tap water.
Three rats in a second group were provided a high carbohydrate
diet and tap water.

After seven days of this adaptation period

food was removed from both groups of animals.

The animals from

the first group were transferred to stainless steel metabolism
cages fitted with urine-feces separators and placed in a cold
room with an environmental temperature of 15°C,

Urine was

collected for the next twenty-four hours in container into
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Table 8

Lipolytic Response to FMS of Adipose Tissue Taken
from Rats Exposed to Cold

Treatment

No.
of
Determinations

C.ontrol

6

Exposed to
Cold

6

Response~.:-

75 + 8.6**
140 + 10.1

*Expressed as percentage increase of free fatty acids (FFA)
as a consequence of addition of 100 ugm of FMS
*{!-Mean + standard deviation

-65which five milliliters of 10% thymol in isopropanol had been
added.

The collected urine was pooled and crude FI\1S was ex-

tracted by the three-stage extraction procedure already described.
The animals from the second group were transferred to
an enviromental temperature of 0° to

5°C for seventy-two hours

and were sacrified to obtain the epididymal fat pads which
would be used for the in vitro bioassay of the FMS preparation.
The aqueous solution of the crude FMS was purified by
means of ultrafiltration using a PM-10 Diaflo membrane.

The

filtrate and the residue were each freeze-dried and bioassayed
in vitro for lipolytic activity.

The results of these analyses

(Table 9) showed that the active material was associated with
the filtrate which was, then, further' ultrafiltered in the same
manner through a UM-2 Diaflo membrane.

Both the filtrate and

the retentate were again lyophilized and assayed for activity.
The activity was found to be associated with the

~1-2

retentate

which was further fractionated by passage through Sephadex
G-50 and BieGel P-10 columns with elution with distilled water.
The elution pattern of the UIVI-2 retentate on Sephadex G- 50
and BioGel P-10 appears in Figure 4.

It can be seen that the

elution peak and the activity peak coincide with each other.
Therefore, fractions

56 to 98 were pooled, lyophilized and the

residue assayed in vitro for lipolytic activity.

-66Table 9
Isolation and Purification of FMS

Source

Urine
Crude
FMS

PM-10
Filtrate

UM-2
Retentate

Material

FFA(umoles)-rr

Control

1.38

Crude
FMS
PM-10
Filtrate
PM-10
Residue
UM-2
Filtrate
UM-2
Retentate
FMS

l·58 + 0.01

P vs Source

+ 0. 02*•*

·2.03.!. 0.02

(0. 001

0.96 + 0.02

>0. 400
<0. 010

2.96 + 0.08

<o. 001

3.88 + 0.12

<0.001

1.18 + 0.15

-

*Expressed as umoles free fatty acids (FFA) released by 100
ug of test mater~al on 250 mg rat epididymal adipose tissue
for 3 hrs. at 37 C•
.**Mean + standard deviation, five determinations
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-68The linear dose-response relationships between lipolysis
and the active fractions are shown in Figure

5·

As can be

seen (Table 9), the activity increased significantly as compared
with the source along.the line of purification.
In order to examine the homogeneity of the FMS preparations, each active fraction

w~s subjecte~

to Microzone

electrophoresis on cellulose acetate at pH 8.6 and the resulting
electrophoresis patterns appear in Figure 6.

FMS migrated as

a single fast-moving spot while the UM-2 retentate migrated as
one major fast-moving protein spot and a weakly-staining slowmoving spot.

PM-10 filtrate migrated as three spots, two of

which v1ere identical to those of the UIVI-2 retentate while the
third one migrated intermediately to the other two.

Crude

FillS was separated into many .spots, all of which were weakly
stained.
The above preparations were further examined for homogeneity by polyacrylamide gel electrophoresis and the results
are shown in Figure 7•
spot.

FIVIS migrated as a single major protein

Crude FivlS was separated into four major protein bands

and many small protein bands.

The PM-10 ultrafiltrate was

separated into two major bandsand numerous small protein bands
were also observed proximal to the one corresponding to that
of FMS.

UM-2 retentate migrated as a single major protein

spot together with many small protein bands.

It is obvious
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-72that some purification of crude FMS was achieved through
ultrafiltration and column chromatography.
In order to verify that the single protein spot observed
in polyacrylamide gel electrophoresis represented FIVIS, unstained
gels were examined for in vitro lipolytic activity and the
analytical data of this experiment appears in Table 10.

While

the non-protein segment of the gel has in vitro lipolytic
activity comparable to that of the c·ontrol, an increased
activity was detectable in the protein segment of gels
ing electrophoresis at pH 8.J.

fo~low

This activity is not as high as

that of the original FMS indicating that there was some loss of
material or activity during the process of electrophoresis but
it does demonstrate that the single protein spot represents FMS.

Tryptic Digestion of FMS

.

In this experiment, FMS was incubated with and without
trypsin and trypsin was incubated without FMS in a medium of
Tris buffer, pH 8.1, containing calcium chloride.

Subsequent

fractionation of the FMS digest with trypsin by ultrafiltration
using PM-10 and

m~-2

Diaflo membranes resulted in a product of

FMS degradation of molecular weight <10, 000 and ;>500 which was
biologically inactive (Table 11).

When FMS was incubated with-

out trypsin and fractionated in an identical manner, an active
fraction indistinguishable from that of the original FMS was
obtained ( p

>0. 4,

paried Student t test) .

-73Table 10
Lipolytic Activity of Unstained Protein Band from
Polyacrylamide Gel Electrophoresis of FMS at pH 8.3

Sample

No.
of
Determinations

In vitro*
Lipolytic
Activity

Control

3

1.31 + 0.02**

Original FMS

3

3.89 .:t o.o6

Extract from
protein segment
of gels
Extract from
nonprotein
segment of gels

3

2.31 + 0.12

3

1.62"+ 0.02

*Expressed as umoles free fatty acids released by 100 ug of
test material ac~ing on 250 mg rat epididymal adipose tissue
for 3 hrs. at 37 C.
**Mean .:t standard deviation, three determinations

-

-74Table 11
Tryptic Digestion of FI'/lS

Treatment of FMS

No.
of
Determinations

In vitro*
Lipolytic
Activity

-+ 0.06**

Control

3

1.~0

Original Fiv1S

3

3·89 + 0.05

Trypsin incubated
(no FMS)

3

1.28 -+ 0.07

FMS incubated
(no trypsin)

3

3.84!. 0.07

FMS incubated with
trypsin

3

0. 95 +

-

o. 08

*Expressed as umoles free fatty acids released by 100 ug of
test material act~ng on 250 mg rat epididymal adipose tissue
for 3 hours at 37.C.
**Mean + standard deviations, three separate incubations.

-75When trypsin was incubated without FMS and the digest was
fractionated in an identical manner, the product after ultrafiltration showed an in vitro lipolytic activity indistinguishable from that of the control system (p>0.4, paired Student
t

test).

The results of this experiment indicates that FMS

is rendered inactive by digestion with trypsin.

This observatio

confirmed the report by Chalmers et al. (1960), who suggested
that FMS appeared to be a

polypeptid~

of undetermined chemical

nature and amino acid sequence.
Cyclic AMP Formation and Lipolysis by Isolated Adipose Tissue
Cells Incubated with FMS
In this experiment, isolated adipose tissue cells labeled
with tritiated adenine were prepared and incubated for 30
minutes at 37°C with varying concentrations of FMS.
accumulation of the labeled cyclic

N~P

The

in the incubation

medium as well as the free fatty acids released to the medium
were determined.

The results of this experiment are shown in

Figure 8 and demonstrate the dose-response relationship between
concentration of FMS and cyclic AMP levels.
The adenyl cyclase activity was expressed as the percentage of response produced by 300 ug of FMS.

Lipolysis was

measured by determining the free fatty acids released over that
the absence of FMS.

Lipolysis was not observed in spite

the high cyclic At'\1P levels indicating that the effect of FMS
cyclic AMP levels was detectable earlier than was lipolysis.
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-77In order to insure that the radioactivity measured represented exclusively cyclic Al;IP, the :Baso 4 supernatants from
various runs were pooled. The solution was lyophilized and
chromatographed over night along with unlabeled cyclic AMP as
carrier.

After locating the cyclic AMP spot by ultraviolet

light, the chromatogram was cut into 0.5

c~

bands and the radio-

activity of each band was counted by liquid scintillation.
Figure 9 demonstrates that the radioactivity in the Baso 4 supernatants was concentrated in the area corresponding to that of
the cyclic

M~P

carrier.

The results of this experiment demon-

strated that the radioactivity measured represented exclusively
cyclic AMP.

Kinetics of Cyclic .AIVIP Formation and Lipolysis by Isolated
Adipose Tissue Cells Incubated with Active and Inactive FMS
100 ugm of FMS was incubated with labeled adipocytes for

various periods of time.

Cyclic AMP accumulation and the degree

of lipolysis were measured as before.

The adenyl cyclase acti-

vity was expressed as the percentage of the response produced
by an incubation time of twenty minutes.

Paper chromatography

of BaSo 4 supernatant fluid obtained in the assay of adenyl cyclase in this experiment also confirmed that the radioactivity
measured represented exclusively cyclic Al\1P (Figure 10).
' The accumulation of cyclic AMP reached a maximum at
about 20 minutes after the adipocytes were exposed to FMS then
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-80began to decline thereafter (Figure 11).

In contrast, lipolysis

was detected only about 60 minutes after the addition of FMS
and it increased steadily thereafter.

The results of this

experiment further demonstrated that cyclic AMP levels were
elevated before lipolysis was detected in adipose tissue cells
treated with FMS.
In order to rule out the possibility of artifacts in the
system, FMS was inactivated by dissolving in distilled water
and then boiling for 5 minutes.

The FMS solution was

coo~ed,

lyophilized and assayed in vitro for lipolytic activity.

The

lyophilized product was found to be inactive (Tabl.e 12).

When

labeled adipocytes were incubated for 20 minutes with varying
concentrations of inactive FMS, cyclic AMP levels were not
elevated (Table 13).

Effect of Theophylline on Lipolysis by Isolated Adipose Cells
Incubated with FMS
· It is well known that theophylline inhibits phosphodiesterase which hydrolyzes cyclic

M~P

to yield

M~P.

Since FMS

increases the levels of cyclic AMP and theophylline prevents
its destruction, a combination of the two should produce a
synergistic effect at a dosage at which, singly, neither one
of them can strongly stimulate lipolysis.

Therefore, to do

this experiment, the smallest dose of FMS and of theophylline
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Cyclic M1P formation and lipolysis by labeled adipocytes
incubated with 100 ugm o:f FlVIS at 37°C for various periods
of time.

Table 12
Inactivation of FMS by Treatment with Heat

Material

FMS
Heat-treated
FMS

No.
of
Experiments

Lipolytic*
Activity

3
-0.39!. 0.52

*Increased release (.umoles) of free fatty acids (FFA) as a
consequence of addition of 100 ug of material acting on 250
mg rat epididymal adipose tissue for 3 hours at 37°C as
compared to release in the absence of the material under
the same experimental conditions.
**Mean :t standard deviation

-83Table 13
Formation of Labeled Cyclic AMP by Adipocytes Incubated
with Heat-Treated FMS

Heat-Treated
FMS(ug)

No. of
Experiments

Radioactivity
Representing
Cyclic AMP
Levels(dpm)

0

3

807 !. 56*

50

3

529 !. 28

100

3

683 + 42

200

3

790 + 29

300

3

605 + 44

lOO(Active FMS)

3

2483 !. 58

Note: Absolute amount of cyclic M~P isolated was not determined
and the radioactivity (dpm) was used to represent the cyclic
· MIIP levels .
*Mean + standard deviation

-84that singly will produce a significant measurable and reproducible response had to be established.

Figure 12 illustrates

a linear dose-response relationship between FMS and lipolysis
up to 125 ug of FMS by isolated adipose tissue cells in a
medium of Krebs-Ringer phosphate buffer, pH 7·4 containing
4% of bovine serum albumin.

As can be

see~,

25 ug of FMS

produced a measurable and reproducible response in the course
of 3 hours incubation at J7°C.
The effect of theophylline on the release of free fatty
acids under the same experimental conditions is illustrated in
Figure lJ.

A measurable and reproducible response was obtained
I

in the presence of 0.25 mM theophylline.
The effect of 0.25 mM theophylline on lipolysis by isolated adipose cells incubated with 25 ug of FMS is demonstrated
in Figure 14.

It is readily seen that neither 0.25 mM

theophylline nor 25 ug of FMS strongly stimulate lipolysis,
but that a combination of the two produces a striking response.
The potentiation of FMS by theophylline can be taken as good
presumptive evidence that FMS acts by stimulating adenyl
cyclase.
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CHAPTER IV
DISCUSSION AND CONCLUSIONS

A Fat-Mobilizing Substance (FMS) has been detected in the
urine of man and some other mammalian species, during fasting
~~d

in several other conditions associated with increased

catabolism of fat.

In vivo, this material increases the plasma

free fatty acids and the turnover rate of fatty acids in adipose
tissue accompanied by a loss of body fat and body weight without
a concomitant decrease in food intake and disturbance of nitrogen
balance.

In vitro, FMS increases the ·release of free fatty

acids from epididymal fat pads into a medium containing bovine
serum albumin.

FMS then is a lipolytic agent.

It appears to

be a low molecular weight polypeptide but its precise chemical
nature and mechanism of action have not yet been determined.
From the information provided by previously reported studies
on many lipolytic agents that utilize cyclic AMP as a second
messenger to promote lipolysis in adipose tissue cells (Butcher
et al. 1965, 1967, Hynie et al. 1966, Weiss et al. 1966 and
Humes et al. 1968), it appeared that cyclic AMP would also play
an important role in lipolysis stimulated by FMS.
This study was concerned with further purification and
characterization of this lipolytic factor and the role of cyclic
~~P

as a possible mediator in iipolysis stimulated by FMS.
In the first part of this study, FMS was prepared accordine

-89the current method which involves benzoic acid precipitation
Fr.rs from the urine of fasting rats, water extraction and
alcoholic precipitation.

In order to develop a condition under

which maximum amount of crude FMS could be obtained per 24 hr.
urine collection, JO day old male albino rats were fed different
diets, exposed to different environmental temperatures and fasted
for various periods of time prior to urine collection.
results obtained in this investigation

The

compared favorably with

those previously reported (Beaton et al. 1966) and indicated that
FliTS can best be extracted from the first 24 hour urine collection
of rats that were fed a high fat diet for 7 days and then fasted
at an environmental temperature of 15°C during which time,· urine
was collected and pooled.
The current in vitro method for the determination of the
lipolytic activity of FMS, as well as for many other adipokinetic substances involves the incubation of the material with
isolated rat adipose tissue under physiological conditions in
the presence of bovine serum albumin and the quantitative estimation by the titration method of Dole (1956) of the free fatty
acids released to the incubation medium.

The condition of the

animals from which the adipose tissue is obtained has to be
delineated.

For this reason, epididymal fat pads from animals

fed different diets, fasted for various periods of time and
subjected to a cold environmental temperature were tested for

in vitro lipolytic response to Ff/IS.

The experimental results

-90indicated that animals fed a high carbohydrate diet and then
st~~ved for 72 hours at 0° to 5°C prior to sacrifice would

provide epididymal fat pads with maximum response to FMS.
The colorimetric method developed by Duncombe (1964)
was adopted throughout for the quantitative determination of
free fatty acids released to the medium.

This is a simple and

rapid method and is sensitive.
In the in vitro bioassay of FMS, some investigators have
employed Krebs-Ringer bicarbonate buffer, pH 7. 4 as the ir:J.Cubation medium with air as the gas phase.
bicarbonate buffer must be done with

Studies done with

5% co 2

in the gas phase

otherwise the final pH of the medium will be around 8.2 to 8.4
(Fain, 1973), a circumstance under which there is a marked increase in basal glucose metabolism, resulting in reesterification
of free fatty acids due to the availability of the
phosphate (Gliemann, 1967).

L~·glycero

For convenience then, Krebs-Ringer

phosphate buffer was used with air as the gas phase in all the
experiments in this dissertation.
The most commonly used gel filtration techniques for the
separation and fractionation of biological materials require
some knowledge of the molecular size of the material for proper
selection of chromatographic conditions.
Chalmers et al. (1960) described FMS as a polypeptide
with molecular weight less than 18,000 while Beaton et al.
(1966) reported that ultrafiltration removed inactive substances

-91with a molecular weight exceeding 30,000.

Undoubtedly, the

approximate molecular weight of the active substance can be
obtained by using Diaflo ultrafiltration.

Therefore, crude

.

F~~

was first fractionated into substances greater than and less
than 10,000 molecular weight by use of a Diaflo ultrafiltration
apparatus fitted with a Piv1-10 membrane.

Subsequent in vitro

bioassay indicated that the fraction with molecular weight
>10,000 did not possess fat-mobilizing activity.
active fraction was further

fractio~ated

When the

.in the same manner

through a UM-2 Diaflo membrane, with
at 1,000 in
- . a cut-off
.
molecular

~eight,

it was found that the active material was

associated with the UM-2 retentate.

Thus it is evident that

the a.ctive material as isolated from rat urine has a molecular
weight between 1,000 to 10,000.
Beaton et al. (1966) reported that fractionation of
their ultrafiltrate on Sephadex G-25 demonstrated the presence
of three active fractions associated with the ultrafiltrate.
The first active fraction coincided with the presence of carbohydrate while the second active fraction coincided with the
presence of carbohydrate and some protein.
fraction coincided with some protein.

The third active

However, when the Uivl-2

retentate was fractionated by passage through a Sephadex G-25
column with elution with distilled water, the activity was found
to be associated only with the first ten 5 ml fractions.

Thus

the results of the experiment suggest that the active material

-92have a molecular weight

>5,000.

Pawan (1971) indicated that some purification of FMS can
be achieved by passage through a column of Sephadex G-50 and
then through a column of Bio-Gel P-10.

When the

m~-2-retentate

was subjected to these two chromatographic columns with elution
with distilled water, the activity peak anq the elution peak
representing the transmission of the effluent at 280 nm, were
found to coincide with each other.
The results of this experiment seem to suggest that the
active material is associated with protein.

However, it is

possible that the protein is present as an inert carrier and
cannot be dissociated from active FlVIS by ultra• and gel-filtrations under the present experimental conditions.

This possi-

bility, however, is ruled out since FMS is inactivated by
digestion with trypsin.

It is now clear that FlVIS prepared and

purified under the present experimental conditions is a polypeptide with a molecular weight between 5,000 and 10,000.
· The homogeneity of the preparations of FMS had to be
established.

This was achieved by subjecting the isolated

preparations which displayed lipolytic activity to cellulose
acetate and polyacrylamide gel electrophoresis.

A single major

protein spot was obtained from the purified FMS preparation with
both electrophoretic techniques.

That the single major protein

spot represented FMS was demonstrated since the aqueous extract
prepared from the relevant segment of unstained polyacrylamide

-93gels exhibited in vitro'lipolytic activity.
In studying the role that cyclic AMP plays in the lipolytic reaction of FMS, isolated fat cells were used in place of
intact epididymal fat pads because of the heterogeneity of the
cell population found in fat pads (Butcher and Baird, 1968) and
the increased sensitivity of isolated fat cells to lipolytic
agents (Fain et al. 1972).

The increased sensitivity may be

due to the uncovering of the receptor·sites during the isolation
of fat cells, the removal of inhibitory materials and the
greater ease of access of the lipolytic agents to the receptor
sites (Fain et al. 1972).
The experimental approaches used in this study were to
satisfy some of the criteria established by Robison et al.
(1971) to justify a claim that a given hormone stimulates
adenyl cyclase.

The present findings demonstrated that FMS was

capable of increasing the intracellular cyclic AMP levels in
intact isolated fat cells while inactive FivlS (heat treated FMS,
proven·to be inactive) did not increase cyclic AMP levels.
Furthermore, the cyclic AMP levels were elevated before lipolysis was detected in cells treated with FMS.

This is con-

sistent with the suggestion of previous investigators (Butcher
and Sutherland, 1962) that cyclic

&~P

is the cellular mediator

of hormone actions and may be related to the lipolytic cascade
proposed by Steinberg (1971).

Thus, after FMS stimulation

of the adenyl cyclase system, cyclic AMP activates protein

-94kinase which in turn phosphorylates the hormone-sensitive
lipase, converting it from a less active to a more active form.
It is this form of the enzyme that control the lipolysis of
triglyceride to free fatty acids.
The potentiation of FMS by theophylline, a phosphodiester
ase inhibitor, was also demonstrated.

Neither 0.25

~~

theophylline nor 25 ug of FMS strongly stimulated lipolysis,
but a combination of the two produced a striking response.
The potentiation of FMS by theophylline can be taken as good
presumptive evidence that FMS acts by stimulating adenyl
cyclase (Robison et al. 1971).
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APPENDIX

Table 14
Dose-Response Relationship between Lipolysis and FMS.at
Different Stages of Purification*

Crude
FMS

PM-10
Filtrate

25

-

-

-

50

-

-

0.80:!: 0.02

75

-

-

-

1.92:!: 0.04

100

. 0.20 + 0.01

0.65 + 0.02

1.58.+ 0.08

2.62 + 0.05

-

J.21 + 0.11

Dose (ug)

125

-

-

150

-

-

200

0 • .36 + 0.04

1.29

.300

0.70 + 0.10

1. 94 :!: 0 • 0.3

400

0.80

.±

0.06

2.59

.±
.±

UM-2
Residue

2.50
0.01

.±

FIV'!S

0.60 + 0.01
1.40

.±

0.12
I

.......
0

+I

0.10

J.04 + 0 • .32

0.04

*Lipolytic activity in vitro is expressed in terms of the increased release (umoles)
of free fatty acids (FFA) over that observed in the absence of added FMS preparations
during the course of .3 hours incubation. All data points represent the mean :!:
standard deviation of five determinations. Portions of the above table are
represented in Figure 5.
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Table 15
Cyclic AMP Formation and Lipolysis of Labeled Adipose
Cells Incubated with FMS

Dose of FMS (ug)

0
25

Adenyl Cyclase*
Activity

Lipolysis**

0

0

9·3 + 4.4***

. -

0.025 + O.OJO***

50

29.1! 11.7

0.008 + 0.010

100

58.1! 16.6

0.050 + 0.063

200

85.9!

6.J

0.100 + 0.080

300

100.

-

0.250

-+

0.120

*Adenyl cyclase activity is expressed as the percentage of the
accumulation of the labeled cyclic AMP in the incubation medium
produded by 300 ug of FMS
**Lipolysis is determined by measuring the free fatty acids
(umoles) released over that in the absence of FMS
***Mean

±

standard deviation, three determinations

Note: Portions of the above table are represented in Figure 8.
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Table 16
Cyclic AMP Formation and Lipolysis of Labeled Adipocytes
Incubated with 100 ug of FMS for Various Periods of Time

Time (Min.)

0
5

Adenyl Cyclase~.~
Activity
0
15.9 + 1.2***

Lipolysis-~*

0
0

10

55.1 + 6".)

0.05 + o. o6-::·**

15

6).9 + 0.6

0.05! O.OJ

20

100

0.05 + 0.04

JO

38.4 + l. 6

0.2) ! 0.02

45

16.7 + 0.2

-

0. 30 ! 0.01

60

0

0.51 + 0.01

120

0

1.)7 + O.OJ

180

0

2.49 + 0.02

-

*Adenyl cyclase activity is expressed as the percentage of the
accumulation of the labeled cyclic AMP in the medium produced
by an incubation time of 20 minutes.
**Lipolysis is determined by measuring the free fatty acids
(umoles) released over that in the absence of added FMS.
***Mean + standard deviation, three separate determinations
Note1 Portions of the above table are represented in Figure 11.
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Table 17
Dose-Response Relationship between FMS and Lipolysis

FMS (ug)

No.
of
Determinations

Lipolysis*

25

5·

0.60 + 0.01**

50.

5

1.40 + 0.12

75

5

1.92 -+ 0.04

100

5

2.62 + 0.05

125

5

).21! 0.11

-

*Lipolysis is determined by measuring the free fatty acids
(umoles) released over that in the absence of added FMS.
**Mean

! standard deviation

Note: Portions of the above table are represented in Figure 12
and Ta ble 14.
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Table 18
Dose-Response Relationship Between Theophylline and Lipolysis

Theophylline

(m~)

No.
of
Determinations

Lipolys is

1

~

0.10

5·

0.05!. o. o4-:~o-l!-

0.25

0.20 + 0.10

0.50

5
5

0.40 -+ 0.14

0.75

5

0.86 + 0.17

1.00

5

1.44 + 0.24
-

1.25

1.90 + 0.25

1. 50

5
5.

1.75

5

2.70 + 0.11

2.00

5

2.80 + 0.07

-

2.J6 + 0.21

*Lipolysis is determined by measuring the free fatty acids
(umoles) released over that in the absence of added theophylline.
**Mean + standard deviation
Note:

Portions of the above table are represented in Figure 1.3. ·
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Abstract of the dissertation entitled "FAT-MOBILIZING
SUBSTANCE (FMS) AND LIPOLYSIS" submitted by Roderic P. Kwok
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy, February, 19?4.

A Fat-Mobilizing Substance (FMS) has been prepared from
the urine of fasting rats by a three-stage extraction procedure
involving benzoic acid precipitation, water extraction and
alcoholic precipitation.
of FMS were studied.

Factors that influence the excretion

It was found that the excretion of FMS

was increased after feeding the animals a high fat diet, whereas
prior feeding with a high carbohydrate diet reduced its excretio •
FMS was excreted in the greatest amount in the first 24 hours
of the fasting period.

Decreasing the environmental temperature

of the animals during the urine collection period from 30° to

5°C resulted in a progressively increased excretion of FMS to a
maximum at 15°C.
· In vitro, FMS has the ability to increase the release of
free fatty acids from epididymal fat pads into a medium containing bovine serum albumin and this parameter has been taken as
the index for measuring the in vitro lipolytic activity of
FMS.

For this purpose, it was found useful to employ epididymal

adipose tissue from rats previously maintained on a high carbohydrate diet and fasted for 72 hours at 5°C.

FMS appears to be protein in nature with a molecular
weight between 5,000 and 10,000 and is inactivated by heat
and digestion with trypsin.

It was purified by ultrafiltration

and column chromatography with Sephadex G-50 and Bio-Gel P-10.
When subjected to electrophoresis on cellulose acetate and
polyacrylamide gel, this material migrated as a single protein
spot.
Investigation of FlVIS with labeled isolated fat cells
indicates strongly that cyclic AMP plays an important role in
lipolysis promoted by FMS.

Incubation of labeled isolated fat
;>

cells for a brief period of time with increasing concentration
of FMS resulted in increased cyclic AMP levels without a significant increase in lipolysis.

When longer incubation times were

employed, lipolysis was observed and it occurred after the
maximal stimulation of the adenyl cyclase.

The fact that cyclic

AMP levels were elevated before lipolysis was detected in cells
treated with FMS is consistent with the current theory that
cyclic AMP is the·cellular mediator of "hormone" actions.
Theophylline, an inhibitor of phosphodiesterase which
hydrolyzes cyclic AMP, acts synergistically with FMS in vitro.
While neither 0.25 mM theophylline nor 25ug of FiviS strongly
stimulated lipolysis, the combination of the two produced a
striking response.

The potentiation of FMS by theophylline

can be taken as good presumptive evidence that FMS acts by
stimulating adenyl cyclase.

Approval Sheet

The dissertation submitted by Roderic p, Kwok has been
read and approved by five members of a committee appointed by
the Dean of th.e Graduate School of Loyola University of Chicago.
The final copies have been examined and the signature
which appears below verifies the fact that any necessary changes
have been incorporated, and that the dissertation is now given
final approval with reference to form, content, and mechanical
accuracy.
The dissertation is t.herefore accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy.

Date

Signature of Advisor

